DaVita to lose money on sale of medical group in order to speed up closing The Citizen 8 years ago The company lowered the sale price of its medical group by $560 million. Source: The Business Journal Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Lovelace Medical Group CEO to retireDateAugust 4, 2023In relation toPolvaderaLovelace Medical Group names new COODateOctober 28, 2024In relation toPolvaderaLovelace Medical Group acquires Albuquerque health care companyDateSeptember 2, 2020In relation toPolvadera
